Literature DB >> 20048081

Characterization of melanoma cells capable of propagating tumors from a single cell.

Matthew A Held1, David P Curley, David Dankort, Martin McMahon, Viswanathan Muthusamy, Marcus W Bosenberg.   

Abstract

Questions persist about the nature and number of cells with tumor-propagating capability in different types of cancer, including melanoma. In part, this is because identification and characterization of purified tumorigenic subsets of cancer cells has not been achieved to date. Here, we report tumor formation after injection of single purified melanoma cells derived from three novel mouse models. Tumor formation occurred after every injection of individual CD34+p75- melanoma cells, with intermediate rates using CD34-p75- cells, and rarely with CD34-p75+ cells. These findings suggest that tumorigenic melanoma cells may be more common than previously thought and establish that multiple distinct populations of melanoma-propagating cells (MPC) can exist within a single tumor. Interestingly, individual CD34-p75- MPCs could regenerate cellular heterogeneity after tumor formation in mice or multiple passages in vitro, whereas CD34+p75- MPCs underwent self-renewal only, showing that reestablishment of tumor heterogeneity is not always a characteristic of individual cells capable of forming tumors. Functionally, single purified MPCs were more resistant to chemotherapy than non-MPCs. We anticipate that purification of these MPCs may allow a more comprehensive evaluation of the molecular features that define tumor-forming capability and chemotherapeutic resistance in melanoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048081      PMCID: PMC4026296          DOI: 10.1158/0008-5472.CAN-09-2153

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.

Authors:  Mingjian James You; Diego H Castrillon; Boris C Bastian; Rónán C O'Hagan; Marcus W Bosenberg; Ramon Parsons; Lynda Chin; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.

Authors:  N Harada; Y Tamai; T Ishikawa; B Sauer; K Takaku; M Oshima; M M Taketo
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Transplantation of human prostatic carcinoma into nude mice in Matrigel.

Authors:  T G Pretlow; C M Delmoro; G G Dilley; C G Spadafora; T P Pretlow
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

5.  Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.

Authors:  Marcus Bosenberg; Viswanathan Muthusamy; David P Curley; Zhenxiong Wang; Cara Hobbs; Betsy Nelson; Cristina Nogueira; James W Horner; Ronald Depinho; Lynda Chin
Journal:  Genesis       Date:  2006-05       Impact factor: 2.487

6.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

7.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

Authors:  Kristin J Hope; Liqing Jin; John E Dick
Journal:  Nat Immunol       Date:  2004-05-30       Impact factor: 25.606

8.  Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor.

Authors:  K Kameyama; T Takemura; Y Hamada; C Sakai; S Kondoh; S Nishiyama; K Urabe; V J Hearing
Journal:  J Invest Dermatol       Date:  1993-02       Impact factor: 8.551

9.  Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.

Authors:  Akira Tamase; Teruyuki Muraguchi; Kazuhito Naka; Shingo Tanaka; Masashi Kinoshita; Takayuki Hoshii; Masako Ohmura; Haruhiko Shugo; Takako Ooshio; Mitsutoshi Nakada; Kazunobu Sawamoto; Masafumi Onodera; Kunio Matsumoto; Masanobu Oshima; Masahide Asano; Hideyuki Saya; Hideyuki Okano; Toshio Suda; Jun-ichiro Hamada; Atsushi Hirao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

10.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  49 in total

1.  Selection of tumorigenic melanoma cells using ALDH.

Authors:  Jim B Boonyaratanakornkit; Lili Yue; Lauren R Strachan; Kenneth J Scalapino; Philip E LeBoit; Ying Lu; Stanley P Leong; Janellen E Smith; Ruby Ghadially
Journal:  J Invest Dermatol       Date:  2010-08-26       Impact factor: 8.551

2.  Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.

Authors:  Victoria Marsh Durban; Marian M Deuker; Marcus W Bosenberg; Wayne Phillips; Martin McMahon
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 3.  Melanocytes, melanocyte stem cells, and melanoma stem cells.

Authors:  Deborah Lang; Joseph B Mascarenhas; Christopher R Shea
Journal:  Clin Dermatol       Date:  2013 Mar-Apr       Impact factor: 3.541

4.  Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: rare resistance is overcome by blocking interferon pathways.

Authors:  Justin C Paglino; Anthony N van den Pol
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

5.  Gold nanoparticle-mediated detection of circulating cancer cells.

Authors:  Kiran Bhattacharyya; Benjamin S Goldschmidt; Mark Hannink; Stephen Alexander; Aleksander Jurkevic; John A Viator
Journal:  Clin Lab Med       Date:  2012-03       Impact factor: 1.935

6.  The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?

Authors:  Tobias Schatton; Markus H Frank
Journal:  J Invest Dermatol       Date:  2010-07       Impact factor: 8.551

7.  Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.

Authors:  Joseph S Dosch; Elizabeth K Ziemke; Amrith Shettigar; Alnawaz Rehemtulla; Judith S Sebolt-Leopold
Journal:  Cancer Res       Date:  2015-09-10       Impact factor: 12.701

8.  Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.

Authors:  Lina Prasmickaite; Birgit Ø Engesaeter; Nirma Skrbo; Tina Hellenes; Alexandr Kristian; Nina K Oliver; Zhenhe Suo; Gunhild M Maelandsmo
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.

Authors:  Jillian M Silva; Christina Bulman; Martin McMahon
Journal:  Mol Cancer Res       Date:  2014-01-14       Impact factor: 5.852

10.  Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma.

Authors:  Walburga Croteau; Molly H Jenkins; Siying Ye; David W Mullins; Constance E Brinckerhoff
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.